Compare Organon & Co. Common Stock (OGN) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Vanguard Information Technology Index Fund ETF — how do they compare? Organon & Co. Common Stock trades at $13.73 (market cap $3.61B), while Vanguard Information Technology Index Fund ETF trades at $120.92 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 47.1× Organon & Co. Common Stock's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Vanguard Information Technology Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Vanguard Information Technology Index Fund ETF for 130 Days on average.
| OGN | VGT | |
|---|---|---|
Market Cap | $3.61B | $170.20B |
Volume | 1,808,049 | 6,852,336 |
Sector | Health | — |
52-Week High | $13.81 | $129.79 |
52-Week Low | $5.70 | $83.59 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $11.03B | — |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
VGT trades at $126.48, down slightly by 0.02% today, but maintains a bullish technical stance with strong moving average signals. The ETF, focused on U.S. technology stocks, has delivered robust historical returns, with recent news highlighting its low expense ratio and concentration in top tech giants like Nvidia, Apple, and Microsoft. A dividend of $0.15 is scheduled for late September 2026.
The outlook for VGT remains positive given technology sector growth and AI-driven momentum, though risks include sector concentration and valuation sensitivity. Investor sentiment is buoyed by strong past performance and institutional inflows, but macroeconomic shifts could pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
